Evolva : announces Chief Financial Officer to depart

EQS Group-Ad-hoc: Evolva Holding SA / Key word(s): Miscellaneous Evolva announces Chief Financial Officer to depart 02-March-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Reinach, March 2, 2021 - Evolva announced today that André Pennartz, CFO of Evolva, is leaving the company for personal reasons with immediate effect.  Oliver Walker, CEO of Evolva, said:«I'd like to thank André Pennartz for his contributions and wish him the best for his future.» Oliver Walker will take on the role of CFO ad interim until a successor is appointed. About Evolva Evolva is a Swiss biotech company focused on the research, development and commercialization of ingredients based on nature. We have leading businesses in Flavors and Fragrances, Health Ingredients and Health Protection. Evolva's employees, half of which are women, are dedicated to make the best products that can contribute to health, wellbeing and sensory enjoyment. Find out more at www.evolva.com. For Evolva multi media content, please visit: https://evolva.com/multimedia-library/. Contact Barbara Duci Head of Investor and Corporate Relations [phone] [phone] [e-mail] End of ad hoc announcement

Language:	English
Company:	Evolva Holding SA
	Duggingerstrasse 23
	4153 Reinach
	Switzerland
Phone:	[phone]
Internet:	www.evolva.com
ISIN:	CH0021218067
Valor:	2121806
Listed:	SIX Swiss Exchange
EQS News ID:	1172252

End of Announcement	EQS Group News Service

1172252  02-March-2021 CET/CEST